Patent ID: 7786164

Claim:
A compound having the formula: D-A-R′-A′-D wherein, D is an anticancer drug moiety, wherein the anticancer drug is selected from the group consisting of paclitaxel, docetaxel, and derivatives thereof; R′ is a moiety selected from the group consisting of: (a) substituted and unsubstituted alkyl, (b) substituted and unsubstituted branched alkyl, (c) substituted and unsubstituted heteroalkyl, (d) substituted and unsubstituted cycloalkyl, (e) substituted and unsubstituted alkenyl, (f) substituted and unsubstituted alkynyl, (g) substituted and unsubstituted aryl, and (h) substituted and unsubstituted aralkyl; A and A′ are independently selected from the group consisting of: (a) —S(═O)—, (b) —SO 2 —, (c) —SO(NR 1 )— (d) —C(═O)— (e) —C(═O)O—, (f) —C(═O)NR 1 —, (g) —C(═O)OC(═O)—, (h) —C(═O)OC(═O)O—, (i) —P(═O)(OR 1 )O—, (j) —P(═O)(NR)O—, (k) —SO 2 O—, (l) —S(═O)NR 1 —, (m) —SO 2 NR 1 —, (n) —O—, and (o) —NHR 1 —, wherein R 1 is selected from hydrogen, C 1-6 n-alkyl, C 3-12 branched alkyl, substituted or unsubstituted C 3-6 cycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted aralkyl.